25 results on '"Mazzaschi G."'
Search Results
2. 1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients
3. 165P Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens
4. 17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients
5. 1352P A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
6. 9P Identification of a μCT-based radiomic signature of CD8+ tumour infiltrating lymphocytes in an orthotopic murine model
7. 2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients
8. 1599P Clinical predictors of 30-day mortality in hospitalized patients with lung cancer: A retrospective single-center observational study
9. 88P Identification of prognostic radio-immune-genetic profiles in patients affected by glioblastoma
10. 1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients
11. Genetic, tissue and circulating PD-L1 profiling to predict the response to immuno-checkpoint inhibitors in advanced NSCLC
12. Identification of a radio-immune signature with high prognostic value in surgically resected NSCLC
13. Differentially regulated high-throughput CT imaging features correlate to distinct tumor immune contextures portraying a radiomic signature with prognostic impact on surgically resected NSCLC
14. Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC
15. Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC
16. Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab
17. Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture
18. 10P - Genetic, tissue and circulating PD-L1 profiling to predict the response to immuno-checkpoint inhibitors in advanced NSCLC
19. 1982PD - Identification of a radio-immune signature with high prognostic value in surgically resected NSCLC
20. 2O - Differentially regulated high-throughput CT imaging features correlate to distinct tumor immune contextures portraying a radiomic signature with prognostic impact on surgically resected NSCLC
21. 1O - Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC
22. 30P - Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC
23. E20 - Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab
24. 1643P - Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with nivolumab
25. 2O - Favorable clinical outcome and response to immunotherapy share a common PD-L1/PD-1 based NSCLC immune contexture
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.